Network pharmacology combined with experimental verification for exploring the potential mechanism of phellodendrine against depression

Abstract The anti-inflammatory effect of phellodendrine (PHE), derived from Phellodendri Chinensis Cortex, has been verified in previous studies. Major depressive disorder (MDD) is associated with immune dysregulation and inflammatory processes. This study aimed to explore the therapeutic effects of...

Full description

Saved in:
Bibliographic Details
Main Authors: Lili Hu, Na Wu, Jue Wang, Donghui Cai
Format: Article
Language:English
Published: Nature Portfolio 2025-01-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-024-84771-9
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832594836878786560
author Lili Hu
Na Wu
Jue Wang
Donghui Cai
author_facet Lili Hu
Na Wu
Jue Wang
Donghui Cai
author_sort Lili Hu
collection DOAJ
description Abstract The anti-inflammatory effect of phellodendrine (PHE), derived from Phellodendri Chinensis Cortex, has been verified in previous studies. Major depressive disorder (MDD) is associated with immune dysregulation and inflammatory processes. This study aimed to explore the therapeutic effects of PHE on MDD through network pharmacology and experimental validation. Multiple databases were used to predict the targets of PHE and MDD. The intersection targets between PHE and MDD were obtained to identify as targets for PHE against MDD, followed by protein–protein interaction network, Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway analyses. Molecular docking was applied to further confirm the anti-MDD effects of PHE. The mitochondrial DNA (mtDNA) copy number, inflammatory cytokines and pathway-related mRNA expressions in PC12 cell were determined via quantitative PCR (qPCR) and enzyme-linked immunosorbent assay to verify our finding. Thirty-eight intersection targets were obtained between PHE and MDD. PHE exerted an anti-MDD effect by regulating SLC6A4, SLC6A3, SLC6A2, MAOA and other targets through serotonergic synapse, salivary secretion, dopaminergic synapse, and cAMP signalling pathway. In vitro, PHE induced an increment in mtDNA copy number compared with the CORT group. PHE affected the levels of IL6 and IL1β with different concentrations. The mRNA levels of CHRM1, HTR1A and key targets of the PI3K/Akt signalling pathway were also influenced. Our research reveals novel mechanisms underlying the anti-MDD effects of PHE through network pharmacology and experiments, which provides a new direction for the development of antidepressants.
format Article
id doaj-art-746572ce330d420fb7f4b5846e7c140c
institution Kabale University
issn 2045-2322
language English
publishDate 2025-01-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-746572ce330d420fb7f4b5846e7c140c2025-01-19T12:18:01ZengNature PortfolioScientific Reports2045-23222025-01-0115111110.1038/s41598-024-84771-9Network pharmacology combined with experimental verification for exploring the potential mechanism of phellodendrine against depressionLili Hu0Na Wu1Jue Wang2Donghui Cai3College of Basic Medicine, Shanxi University of Chinese MedicineCollege of Basic Medicine, Shanxi University of Chinese MedicineCollege of Basic Medicine, Shanxi University of Chinese MedicineCollege of Basic Medicine, Shanxi University of Chinese MedicineAbstract The anti-inflammatory effect of phellodendrine (PHE), derived from Phellodendri Chinensis Cortex, has been verified in previous studies. Major depressive disorder (MDD) is associated with immune dysregulation and inflammatory processes. This study aimed to explore the therapeutic effects of PHE on MDD through network pharmacology and experimental validation. Multiple databases were used to predict the targets of PHE and MDD. The intersection targets between PHE and MDD were obtained to identify as targets for PHE against MDD, followed by protein–protein interaction network, Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway analyses. Molecular docking was applied to further confirm the anti-MDD effects of PHE. The mitochondrial DNA (mtDNA) copy number, inflammatory cytokines and pathway-related mRNA expressions in PC12 cell were determined via quantitative PCR (qPCR) and enzyme-linked immunosorbent assay to verify our finding. Thirty-eight intersection targets were obtained between PHE and MDD. PHE exerted an anti-MDD effect by regulating SLC6A4, SLC6A3, SLC6A2, MAOA and other targets through serotonergic synapse, salivary secretion, dopaminergic synapse, and cAMP signalling pathway. In vitro, PHE induced an increment in mtDNA copy number compared with the CORT group. PHE affected the levels of IL6 and IL1β with different concentrations. The mRNA levels of CHRM1, HTR1A and key targets of the PI3K/Akt signalling pathway were also influenced. Our research reveals novel mechanisms underlying the anti-MDD effects of PHE through network pharmacology and experiments, which provides a new direction for the development of antidepressants.https://doi.org/10.1038/s41598-024-84771-9PhellodendrineDepressionNetwork pharmacologyBioinformaticsPI3K-Akt signalling pathway
spellingShingle Lili Hu
Na Wu
Jue Wang
Donghui Cai
Network pharmacology combined with experimental verification for exploring the potential mechanism of phellodendrine against depression
Scientific Reports
Phellodendrine
Depression
Network pharmacology
Bioinformatics
PI3K-Akt signalling pathway
title Network pharmacology combined with experimental verification for exploring the potential mechanism of phellodendrine against depression
title_full Network pharmacology combined with experimental verification for exploring the potential mechanism of phellodendrine against depression
title_fullStr Network pharmacology combined with experimental verification for exploring the potential mechanism of phellodendrine against depression
title_full_unstemmed Network pharmacology combined with experimental verification for exploring the potential mechanism of phellodendrine against depression
title_short Network pharmacology combined with experimental verification for exploring the potential mechanism of phellodendrine against depression
title_sort network pharmacology combined with experimental verification for exploring the potential mechanism of phellodendrine against depression
topic Phellodendrine
Depression
Network pharmacology
Bioinformatics
PI3K-Akt signalling pathway
url https://doi.org/10.1038/s41598-024-84771-9
work_keys_str_mv AT lilihu networkpharmacologycombinedwithexperimentalverificationforexploringthepotentialmechanismofphellodendrineagainstdepression
AT nawu networkpharmacologycombinedwithexperimentalverificationforexploringthepotentialmechanismofphellodendrineagainstdepression
AT juewang networkpharmacologycombinedwithexperimentalverificationforexploringthepotentialmechanismofphellodendrineagainstdepression
AT donghuicai networkpharmacologycombinedwithexperimentalverificationforexploringthepotentialmechanismofphellodendrineagainstdepression